CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,122 shares (to pay taxes)
- 4 Exercise or conversion EVP, Chief Development Officer acquired 3,874 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 13,797 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 62,500 shares (option exercise)
- 4 Grant or award Director acquired 13,948 shares (grant or award)
- 4 Grant or award Director acquired 13,948 shares (grant or award)
- 4 Grant or award Director acquired 13,948 shares (grant or award)
- 4 Grant or award Director acquired 13,948 shares (grant or award)
- 4 Grant or award Director acquired 13,948 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 756 shares (to pay taxes)
- 4 Open-market buy EVP, Chief Development Officer bought 25,000 shares at $1.09 ($27,250)
- 4 Open-market buy EVP, Chief Development Officer bought 50,000 shares at $0.94 ($46,995)
- 4 Open-market buy Chief Executive Officer bought 150,000 shares at $0.92 ($137,970)
- 4 Open-market buy EVP, Chief Financial Officer bought 85,000 shares at $0.89 ($75,599)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 15,603 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 692 shares (to pay taxes)
Page 6 of 30 · 585 filings